A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorWeill Medical College of Cornell University

About this trial

The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female;

Documented history of previous breast surgery (either complete or partial mastectomy);

Available harvest sites for fat grafting as documented by plastic surgeon;

BMI > 20;

Disqualifiers

Suspected or known to be pregnant

Trial design

Design model

Parallel

Treatments tested in this trial

  • REVOLVE Advanced Adipose System

    Device

    The REVOLVE system is an all-in-one fat processing device that harvests, filters, actively washes, and removes strands from lipoaspirate and allows for reinjection without any additional manipulation (REVOLVE 2020).

  • LipoGrafter

    Device

    The LipoGrafter system is designed to be a start-to-finish closed system with minimal processing of the lipoaspirate, minimizing the risk of contamination and fat cell damage (LipoGrafter 2020).

  • Viality

    Procedure/Surgery

    The Viality system uses the AuraClens solution that acts as a surfactant to bring impurities like blood, free oil, and cellular debris into solution, where they can be flushed out through suction.

Treatment groups

135 Participants
are divided into 3 treatment groups
Group A: REVOLVE Advanced Adipose SystemActive comparator 1 intervention
Group B: LipoGrafterActive comparator 1 intervention
Group C: VialityActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in efficacy of fat grafting technique, as measured by 3D volumetric scanning at the surgical site

3D volumetric scanning assesses the fat graft retention defined as the ratio of fat remaining at the surgical site at 90 day follow-up to that at pre-operative baseline.

Time frame
Baseline, 90 day follow-up
2

Change in patient satisfaction of fat grafting technique, as measured by the BREAST-Q questionnaire

The BREAST-Q questionnaire is used for measuring pre- and postoperative psychosocial, physical, and sexual well-being, satisfaction with breasts, experience of care, and satisfaction with outcome. Scores range on a 0-100 scale, with higher scores indicating better outcomes.

Time frame
Baseline, 90 day follow-up

Secondary outcomes

1

Number of palpable masses from the fat grafting technique, as measured by a physical exam.

The physical exam will provide the number of palpable masses at the surgical site.

Time frame
90 day follow-up
2

Number of lesions of probable fat necrosis from the fat grafting technique, as measured by a physical exam

The physical exam will provide the number of lesions of probable fat necrosis at the surgical site

Time frame
90 day follow-up
3

Presence of infection from the fat grafting technique, as measured by a physical exam

The physical exam will show if there is infection present at the surgical site. This is a binary "yes/no" item.

Time frame
90 day follow-up
4

Presence seroma from the fat grafting technique, as measured by a physical exam

The physical exam will show if there is seroma present at the surgical site. This is a binary "yes/no" item.

Time frame
90 day follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.